SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-010253
Filing Date
2021-04-29
Accepted
2021-04-29 17:01:14
Documents
10
Period of Report
2021-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlcc20210429_8k.htm 8-K 20177
2 EXHIBIT 10.1 ex_245071.htm EX-10.1 5127
3 a01.jpg GRAPHIC 161405
4 a02.jpg GRAPHIC 462172
5 a03.jpg GRAPHIC 202395
6 a04.jpg GRAPHIC 254113
7 a05.jpg GRAPHIC 482886
8 a06.jpg GRAPHIC 430892
9 a07.jpg GRAPHIC 84462
10 logo.jpg GRAPHIC 8609
  Complete submission text file 0001437749-21-010253.txt   2900616
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55181 | Film No.: 21871782
SIC: 2833 Medicinal Chemicals & Botanical Products